Evaluation of cardiac autonomic dysfunction using electrocardiography in type 2 diabetes mellitus patients: a case-control study
DOI:
https://doi.org/10.18203/2320-6012.ijrms20253175Keywords:
Type 2 diabetes mellitus, QTc prolongation, Heart rate variability, Electrocardiography, Cardiac autonomic neuropathy, Cardiac dysautonomiaAbstract
Background: Type 2 diabetes mellitus (T2DM) is associated with a high risk of cardiovascular complications, including cardiac autonomic neuropathy (CAN), which significantly increases morbidity and mortality. Electrocardiography (ECG) offers a non-invasive method to detect cardiac dysautonomia early. This study aimed to evaluate ECG changes in T2DM patients and correlate them with cardiac autonomic dysfunction.
Methods: A cross-sectional observational study was conducted on 50 T2DM patients and 50 age- and gender-matched healthy controls. Standard 12-lead ECG was performed to assess heart rate, RR interval, PR interval, QRS duration, QRS axis, and QTc interval. Cardiac autonomic function was evaluated using heart rate variability (HRV) parameters and clinical autonomic tests. Statistical analysis was performed to compare ECG parameters and prevalence of ischemic and conduction abnormalities between groups.
Results: T2DM patients exhibited significantly higher mean heart rates (86.9±10.81 versus 78.78±11.26 beats/minute; p=0.001), prolonged PR interval (162.40±31.72 versus 138.20±16.98 msec; p=0.001), increased QRS duration (70.98±12.72 versus 65±8.63 msec; p=0.007), and prolonged QTc interval (410.63±43.80 versus 329.20±29.74 msec; p=0.001) compared to controls. Additionally, ischemia (20% versus 4%; p=0.01), infarction (22% versus 6%; p=0.02), and conduction blocks (14% versus 2%; p=0.02) were significantly more prevalent in T2DM patients. HRV analysis indicated reduced autonomic function in the diabetic group.
Conclusions: T2DM is associated with significant ECG abnormalities reflecting cardiac dysautonomia and increased cardiovascular risk. ECG can serve as a valuable tool for early detection of CAN in diabetic patients, enabling timely intervention to reduce adverse outcomes.
Metrics
References
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. DOI: https://doi.org/10.1016/j.diabres.2021.109119
Siam NH, Snigdha NN, Tabasumma N, Parvin I. Diabetes mellitus and cardiovascular disease: exploring epidemiology, pathophysiology, and treatment strategies. Rev Cardiovasc Med. 2024;25(12).436. DOI: https://doi.org/10.31083/j.rcm2512436
Motataianu A, Barcutean LI, Maier S, Balasa A, Stoian A. Cardiac autonomic neuropathy in diabetes mellitus patients- are we aware of the consequences? Acta Maris Ser Med. 2020;66(1):3-8. DOI: https://doi.org/10.2478/amma-2020-0003
Kaze AD, Fonarow GC, Echouffo‐Tcheugui JB. Cardiac autonomic dysfunction and risk of silent myocardial infarction among adults with type 2 diabetes. J Am Heart Assoc. 2023;12(20):e029814. DOI: https://doi.org/10.1161/JAHA.123.029814
Cha SA. Heart rate-corrected QT interval prolongation is associated with decreased heart rate variability in patients with type 2 diabetes. Medicine. 2022;101(45):e31511. DOI: https://doi.org/10.1097/MD.0000000000031511
John APP, Udupa K, Avangapur S, Sujan MU, Inbaraj G, Vasuki PP, et al. Cardiac autonomic dysfunctions in type 2 diabetes mellitus: an investigative study with heart rate variability measures. Am J Cardiovasc Dis. 2022;12(4):224-32.
Ninkovic VM, Ninkovic SM, Miloradovic V, Stanojevic D, Babic M, Giga V, et al. Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes. Acta Diabetol. 2016;53(5):737-44. DOI: https://doi.org/10.1007/s00592-016-0864-y
John APP, Udupa K, Avangapur S, Sujan MU, Inbaraj G, Vasuki PP, et al. Cardiac autonomic dysfunctions in type 2 diabetes mellitus: an investigative study with heart rate variability measures. Am J Cardiovasc Dis. 2022;12(4):224-32.
Prajna GS, Krishna S, Rao M, Graduate P, Medicine G, Sitarama A, et al. A study on ecg changes in diabetic patients and its relation to cardiac dysautonomia. Int J Sci Res. 2019;(11):73-5.
Inapakolla LP, Kotla RT. A study of cardiological autonomic neuropathy in type 2 diabetes mellitus with reference to QT interval for its diagnosis. Int J Res Med Sci. 2019;7(7):2574-7. DOI: https://doi.org/10.18203/2320-6012.ijrms20192880
Prasad VC, Savery DM, Prasad VR. Cardiac autonomic dysfunction and ECG abnormalities in patients with type 2 diabetes mellitus: a comparative cross-sectional study. Nat J Physiol Pharm Pharmacol. 2016;6(3):178-81. DOI: https://doi.org/10.5455/njppp.2016.6.27122015107
Marques KC, Quaresma JAS, Falcão LFM. Cardiovascular autonomic dysfunction in “long COVID”: pathophysiology, heart rate variability, and inflammatory markers. Front Cardiovasc Med. 2023;10:1256512. DOI: https://doi.org/10.3389/fcvm.2023.1256512
Furuya M, Masuda Y, Sato K, Nishibe T, Yana K, Ono T. Long and short term QT-RR interval co-variability in type 2 diabetes. Annu Int Conf IEEE Eng Med Biol Soc. 2014;2014:38-41. DOI: https://doi.org/10.1109/EMBC.2014.6943523
Amekran Y, Damoun N, El Hangouche AJ. A focus on the assessment of the autonomic function using heart rate variability. Glob Cardiol Sci Pract. 2025;2025(1):e202512. DOI: https://doi.org/10.21542/gcsp.2025.12
Tyagi R, Tyagi S, Samant AC, Vadasmiya D. A comparative study of autonomic function tests in type 2 diabetics and healthy controls. Eur J Cardiovasc Med. 2024;14:710-4.
Smail M, Rupee S, Rupee K, Ismail AM, Sultan S, Howarth FC, Adeghate EA, Singh J. Effects of Diabetes Mellitus on the Conduction System of the Heart: Mini-Review. New Insights Cardiomyopath. 2022.
Gallego M, Zayas-Arrabal J, Alquiza A, Apellaniz B, Casis O. Electrical Features of the Diabetic Myocardium. Arrhythmic and Cardiovascular Safety Considerations in Diabetes. Front Pharmacol. 2021;12:687256. DOI: https://doi.org/10.3389/fphar.2021.687256
Isaksen JL, Sivertsen CB, Jensen CZ, Graff C, Linz D, Ellervik C, et al. Electrocardiographic markers in patients with type 2 diabetes and the role of diabetes duration. J Electrocardiol. 2024;84:129-36. DOI: https://doi.org/10.1016/j.jelectrocard.2024.04.003
Ehrhardt-Humbert L, Singleton MJ. Physiologic measures in diabetes: QTc prolongation. In: Biomarkers in Diabetes Cham: Springer International Publishing; 2022:113. DOI: https://doi.org/10.1007/978-3-030-81303-1_44-1